Regulation of medical devices used in diabetology in Europe: Time for reform?

Diabetologia

Volumn 55, Issue 8, 2012, Pages 2295-2297

  Boulton, A J M ^a   Del Prato, S ^a  

^a European Association for the Study of Diabetes   (Germany)

Author keywords

Clinical diabetes; Devices; Insulin therapy

Indexed keywords

INSULIN;

BLOOD GLUCOSE MONITORING; CERTIFICATION; DEVICE SAFETY; DIABETES MELLITUS; DIABETIC KETOACIDOSIS; DIABETOLOGY; EUROPE; GLYCEMIC CONTROL; LETTER; MEDICAL DEVICE; MEDICAL SOCIETY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; QUALITY CONTROL; REGISTRATION; RISK ASSESSMENT;

DEVICE APPROVAL; DIABETES MELLITUS, TYPE 1; EQUIPMENT AND SUPPLIES; EQUIPMENT SAFETY; EUROPE; FEMALE; HUMANS; MALE;

EID: 84866359621     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2580-7     Document Type: Letter

References (20)

1. Horton R (2012) Offline: the scandal of device regulation in the UK. Lancet 379:204
2. Fraser AG, Daubert J-C, van de Werf F et al (2011) Clinical evaluation of cardiovascular devices: principles, problems, and proposals for European regulatory reform. Eur Heart J 32:1673-1686
3. Berry M, Stanek JJ (2012) The PIP mammary prosthesis: a product recall study. J Plast Reconstr Aesthet Surg 9. doi:10.1016/j.bjps.2012.02.019
4. Cohen D (2012) Hip implants: how safe is metal on metal? BMJ 344:e3410
5. Torjesen I (2012) NHS should replace PIP implants even if they have been privately fitted. BMJ 344:e2379
6. Hauser RG (2012) Here we go again-failure of post-marketing device surveillance. NEJM 366:873-875
7. Hauser RG, Abdelhadi R, McGriff D, Retel LK (2012) Deaths caused by the failure of Riata and Riata ST implantable cardioverter-defibrillator leads. Heart Rhythm. doi:10.1016/j.hrthm.2012.03.048
8. EASD (2012) Report on stakeholder meeting on European perspectives of medical devices in diabetology. Diabetologia News Section 06/2012
9. Sönksen PH, Judd SL, Lowy C (1978) Home monitoring of bloodglucose. Method for improving diabetic control. Lancet 1:729-732
10. Skyler JS, Lasky IA, Skyler DL, Robertson EG, Mintz DH (1978) Home blood glucose monitoring as an aid in diabetes management. Diabetes Care 1:150-157
11. Pickup JC, Keen H, Parsons JA, Alberti KG (1978) Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. BMJ 1:204-207
12. Pickup JC (2012) Management of diabetes mellitus: is the pump mightier than the pen? Nat Rev Endocrinol. doi:10.1038/nrendo.2012
13. Battelino T, Ursic-Bratina N, Bratanic N, Zerjav-Tansek M, Avbelj M, Krzisnik C (2004) The use of continuous subcutaneous insulin infusion (CSII) as the treatment of choice in children and adolescents with type 1 diabetes. Pediatr Endocrinol Rev 1:537-539
14. Moser EG, Morris AA, Garg SK (2012) Emerging diabetes therapies and technologies. Diabetes Res Clin Pract. doi:10.1016/j.diabres.2012.01.027
15. Batttelino R, Bolinder J (2008) Clinical use of real-time continuous glucose monitoring. Curr Diabetes Rev 4:218-222
16. Knight G, Jennings AM, Boulton AJ, Tomlinson S, Ward JD (1985) Severe hyperkalaemia and ketoacidosis during routine treatment with an insulin pump. BMJ 291:371-372
17. Wentholt IM, Hoekstra JB, Zwart A, de Vries JH (2005) Pendra goes Dutch: lessons for the CE mark in Europe. Diabetologia 48:1055-1058
18. Wentholt IM, Hart AA, Hoekstra JB, de Vries JH (2008) How to assess and compare the accuracy of continuous glucose monitors? Diabetes Technol Ther 10:57-68
19. European Commission (2010) Medical devices. Guidance documents. Classification of medical devices. MEDDEV 2.4/1 Rev 9 June
20. Schouten R, Rijs C, Bouvy N et al (2010) A multicentre, randomized efficacy study of the EndoBarrier gastrointestinal liner for presurgical weight loss prior to bariatric surgery. Ann Surg 251:236-243